Fig. 1From: Proof of principle for bevacizumab activity in desmoid-type fibromatosisMRI of the right shoulder showing the tumor extent at the time of initial diagnosis in proton density (PD)-weighted (a) and T1-weighted contrast-enhanced (b) sequences. An inhomogeneously enhancing, partially fibrotic tumor (white arrows) originating from the right thoracic wall is clearly visible consistent with a desmoid-type fibromatosisBack to article page